OESO-SEMPIRE 17th World Conference | Esophagus 2026 | Versailles | June 14-17, 2026

Session 12: Eosinophilic Esophagitis: State of the Art

Monday June 15, 4:00 – 5:30 pm
Auditorium Condé

ChairsNirmala Gonsalves (USA) – Pierfrancesco Visaggi (Italy)
Discussants: Jennifer Horsley-Silva (USA) – Emily McGowan (USA)

    I. Diagnosis, Clinical Presentation & Pathophysiology

  1. What is the true prevalence of EoE and is it increasing? – Mayssan Muftah (USA)
  2. What do we know about the microbiome in EoE or assessing endoscopic severity? – Alex Strauss (USA)
  3. Is an allergist required for care of the EoE patient in 2026? – Matthew Greenhawt (USA)
  4. How should esophageal biopsies ideally be analyzed for EoE patients? TBD
  5. What is the role for non-endoscopic techniques for diagnosis & surveillance? TBD
  6. What is the EoE experience in Japan? TBD

    Panel Chat/Q&A


    II. Management

     
  7. Is there still a role for proton pump inhibitors in the management of EoE? – Ellen Stein (USA)
  8. Topical steroids: who, what & how long? – Jennifer Horsley-Silva (USA)
  9. How to approach biologic therapies for EoE in 2026? – Joshua Sloan (USA)
  10. How I approach endoscopic dilation for EoE – William Ravich (USA)
  11. What to do with the EoE patient who becomes pregnant? – Claire Beveridge (USA)
  12. Is EoE therapy forever? – John O. Clarke (USA)

   Panel Chat/Q&A